CSIMarket


Vir Biotechnology Inc.  (VIR)
Other Ticker:  
 


 

Vir Biotechnology Inc.

VIR's Financial Statements and Analysis



Vir Biotechnology Inc. reported II. Quarter net loss per share of $-0.58 compare to earnings per share of $0.46 in the same quarter a year ago a decrease from $3.85 eps realized in I. Quarter (Mar 31 2022).


II. Quarter
Earnings Per Share Revenues
$ -0.58 $  -41 Mill
$-1.04     $-218M    



Vir Biotechnology's Revenue fell by -122.95 % in II. Quarter (Jun 30 2022) year on year, to $-41 million and declined by sequentially.


Vir Biotechnology is Expected to report next financial results on November 03, 2022.

More on VIR's Income Statement



Vir Biotechnology's in II. Quarter recorded net loss of $-76.493 million, compare to net income of $61.813 million achieved in II. Quarter a year ago.

Sequentially company realized net loss, compare to net income of $518.621 million in previous quarter.

More on VIR's Growth

VIR's Cash flow In II. Quarter company's net cash flow was $691 million, capital expenditures fell by 891.72%, to $-21 millions compare to same quarter a year ago and fell by 30.03% from I. Quarter (Mar 31 2022).

More on VIR's Cash flow Statement


Vir Biotechnology Inc. does not pay out common stock dividend.

In trailing twelve-month period Vir Biotechnology Inc. earned $ 10.66 cash per share, on a free-cash flow basis 135.13 % of net earning per share.

Book value fell by -0.91 % sequentially to $14.74 per share.
Tangible Book value fell to $ 14.36 per share from $ 14.50.

Company repurchased 2.09 million shares or 1.55 % in II. Quarter.


More on VIR's Dividends

 Market Capitalization (Millions) 2,462
 Shares Outstanding (Millions) 132
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 1,078
 Cash Flow (TTM) (Millions $) 771
 Capital Exp. (TTM) (Millions $) -56
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Vir Biotechnology Inc. does not pay out common stock dividend.

In trailing twelve-month period Vir Biotechnology Inc. earned $ 10.66 cash per share, on a free-cash flow basis 135.13 % of net earning per share.

Book value fell by -0.91 % sequentially to $14.74 per share.
Tangible Book value fell to $ 14.36 per share from $ 14.50.

Company repurchased 2.09 million shares or 1.55 % in II. Quarter.


More on VIR's Balance Sheets

 Market Capitalization (Millions) 2,462
 Shares Outstanding (Millions) 132
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 1,078
 Cash Flow (TTM) (Millions $) 771
 Capital Exp. (TTM) (Millions $) -56
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -


   



       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

TLYS's Profile

Stock Price

TLYS's Financials

Business Description

Fundamentals

Charts & Quotes

TLYS's News

Suppliers

TLYS's Competitors

Customers & Markets

Economic Indicators

TLYS's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071